| Name |
CAS |
MF |
MW |
Single-letter sequence |
Three-letter sequence |
Number of AA |
Type |
Inquiry |
| CSSTRESAC |
|
C33H56N12O16S2 |
941 |
H2N–CSSTRESAC–OH |
H2N–Cys–Ser–Ser–Thr–Arg–Glu–Ser–Ala–Cys–OH |
9 |
Breast tumor–targeting peptide |
|
| BP1 |
|
C70H83N11O21S2 |
1478.6 |
H2N-EEYCFYDPYFC-OH |
H2N-Glu-Glu-Tyr-Cys-Phe-Tyr-Asp-Pro-Tyr-Phe-Cys-OH |
11 |
BCMA-targeting peptide |
|
| CSDSWHYWC |
|
C53H63N13O15S2 |
1186.28 |
H2N-CSDSWHYWC-OH |
H2N-Cys-Ser-Asp-Ser-Trp-His-Tyr-Trp-Cys-OH |
9 |
VEGFR-3–targeting peptide |
|
| CTKNSYLMC |
|
C43H71N11O14S3 |
1062.28 |
H2N-CTKNSYLMC-OH |
H2N-Cys-Thr-Lys-Asn-Ser-Tyr-Leu-Met-Cys-OH |
9 |
HUVEC-targeting peptide |
|
| EILDVPST |
|
C38H64N8O15 |
872.96 |
H2N-EILDVPST-OH |
H2N-Glu-Ile-Leu-Asp-Val-Pro-Ser-Thr-OH |
8 |
α4β1-targeting peptide |
|
| GEEIQIGHIPREDVDYHLP |
|
C98H149N27O32 |
2217.39 |
H2N-GEEIQIGHIPREDVDYHLP-OH |
H2N-Gly-Glu-Glu-Ile-Gln-Ile-Gly-His-Ile-Pro-Arg-Glu-Asp-Val-Asp-Tyr-His-Leu-Pro-OH |
19 |
α4β1-targeting peptide |
|
| XQ2B |
2104728-28-9 |
C59H92N16O11 |
1201.46 |
Cyclo({d-Phe}-ATRL-{d-Phe}-PVRL) |
Cyclo({d-Phe}-Ala-Thr-Arg-Leu-{d-Phe}-Pro-Val-Arg-Leu) |
9 |
cGAS Inhibitor |
|
| 1-D03 |
|
C68H108N18O22S3 |
1625.89 |
H2N-MEGPSKCCYSLALSH-OH |
H2N-Met-Glu-Gly-Pro-Ser-Lys-Cys-Cys-Tyr-Ser-Leu-Ala-Leu-Ser-His-OH |
15 |
ErbB2-targeting peptide |
|
| AHNP |
|
C66H85N13O19S2 |
1428.59 |
H2N-FCDGFYACYKDV-OH |
H2N-Phe-Cys-Asp-Gly-Phe-Tyr-Ala-Cys-Tyr-Lys-Asp-Val-OH |
12 |
HER2-targeting peptide |
|
| (K)6GRGDSPC |
|
C61H114N22O17S1 |
1459.76 |
H2N-KKKKKKGRGDSPC-OH |
H2N-Lys-Lys-Lys-Lys-Lys-Lys-Gly-Arg-Gly-Asp-Ser-Pro-Cys-OH |
13 |
BMSC-targeting peptide |
|
| CTVRTSADC |
|
C35H60N12O15S2 |
953.05 |
H2N-CTVRTSADC-OH |
H2N-Cys-Thr-Val-Arg-Thr-Ser-Ala-Asp-Cys-OH |
9 |
EDB-FN–targeting peptide |
|
| GL10 |
|
C49H71N15O17S |
1174.24 |
H₂N–GHSQECSEWL–NH₂ |
H₂N–Gly–His–Ser–Gln–Glu–Cys–Ser–Glu–Trp–Leu–NH₂ |
10 |
Trop2-targeting peptide |
|
| P12 |
|
C61H89N13O19S1 |
1340.5 |
H2N–LSMPWSPTTYAS–OH |
H2N–Leu–Ser–Met–Pro–Trp–Ser–Pro–Thr–Thr–Tyr–Ala–Ser–OH |
12 |
IGF2BP2-targeting peptide |
|
| KDEPQRRSARLSAKPAPPK- PEPKPKKAPAKK |
|
C152H263N49O41 |
3433.02 |
H2N-KDEPQRRSARLSAKPAPPKPEPKPKKAPAKK-OH |
H2N-Lys-Asp-Glu-Pro-Gln-Arg-Arg-Ser-Ala-Arg-Leu-Ser-Ala-Lys-Pro-Ala-Pro-Pro-Lys-Pro-Glu-Pro-Lys-Pro-Lys-Lys-Ala-Pro-Ala-Lys-Lys-OH |
31 |
Nucleolin-targeting peptide |
|
| YSA |
|
C59H86N12O20S2 |
1347.51 |
H2N-YSAYPDSVPMMS-OH |
H2N-Tyr-Ser-Ala-Tyr-Pro-Asp-Ser-Val-Pro-Met-Met-Ser-OH |
12 |
EphA2 receptor–targeting peptide |
|
| (KLAKLAK)2 |
|
C72H138N20O15 |
1523.99 |
H2N-KLAKLAKKLAKLAK-OH |
H2N-Lys-Leu-Ala-Lys-Leu-Ala-Lys-Lys-Leu-Ala-Lys-Leu-Ala-Lys-OH |
14 |
Mitochondria-targeting peptide |
|
| CMYIEALDKYAC |
|
C62H93N13O19S3 |
1420.67 |
H2N-CMYIEALDKYAC-OH |
H2N-Cys-Met-Tyr-Ile-Glu-Ala-Leu-Asp-Lys-Tyr-Ala-Cys-OH |
12 |
EGFR-targeting peptide |
|
| YW7 |
|
C46H60N12O11 |
957.04 |
H2N-YWRGVYN-OH |
H2N-Tyr-Trp-Arg-Gly-Val-Tyr-Asn-OH |
7 |
ANXA2-targeting peptide |
|
| pm26TGF-β1 peptide |
|
C51H88N18O18S2 |
1305.48 |
H2N-ACEPLKRQCGGGS-OH |
H2N-Ala-Cys-Glu-Pro-Leu-Lys-Arg-Gln-Cys-Gly-Gly-Gly-Ser-OH |
13 |
|
|
| RS17 |
|
C96H130N30O26 |
2120.24 |
H2N-RRYKQDGGWSHWSPWSS-OH |
H2N-Arg-Arg-Tyr-Lys-Gln-Asp-Gly-Gly-Trp-Ser-His-Trp-Ser-Pro-Trp-Ser-Ser-OH |
17 |
CD47-targeting peptide |
|
